Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Intangibles: 2012-2018

Historic Change in Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Dec 2018 value amounting to $4.4 million.

  • Amphastar Pharmaceuticals' Change in Intangibles fell 96.57% to $151,000 in Q1 2019 from the same period last year, while for Mar 2019 it was $6.6 million, marking a year-over-year increase of 2.12%. This contributed to the annual value of $4.4 million for FY2018, which is 120.00% up from last year.
  • As of FY2018, Amphastar Pharmaceuticals' Change in Intangibles stood at $4.4 million, which was up 120.00% from $2.0 million recorded in FY2017.
  • In the past 5 years, Amphastar Pharmaceuticals' Change in Intangibles registered a high of $4.4 million during FY2018, and its lowest value of $2.0 million during FY2017.
  • Its 2-year average for Change in Intangibles is $3.2 million, with a median of $3.2 million in 2017.
  • Data for Amphastar Pharmaceuticals' Change in Intangibles shows a peak YoY spiked of 120.00% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows Amphastar Pharmaceuticals' Change in Intangibles stood at $2.0 million in 2017, then soared by 120.00% to $4.4 million in 2018.